車 T 細胞スフェロイド殺害アッセイ

Overview

This protocol is designed to assess immunotherapeutic redirected T-cell (CAR T-cell) cytotoxicity against 3D structured cancerous cells (spheroids) in real time. The method combines advanced imaging technology with a sensitive immunological assay to evaluate immune cell effectiveness.

Key Study Components

Area of Science

• Immunotherapy
• Cancer Biology
• Cellular Assays

Background

• Immunotherapy is a promising approach in cancer treatment.
• Understanding T-cell cytotoxicity is crucial for developing effective therapies.
• 3D tumor models better mimic the in vivo environment compared to traditional 2D cultures.
• Real-time assessment allows for dynamic monitoring of cell interactions.

Purpose of Study

• To evaluate the cytotoxic effects of CAR T-cells on 3D tumor spheroids.
• To provide a straightforward method for assessing immune responses.
• To enhance understanding of T-cell behavior in a 3D context.

Methods Used

• Washing colorectal cancer cell lines with PBS.
• Detaching cells using trypsin and confirming under a microscope.
• Neutralizing trypsin with complete medium and centrifuging cells.
• Resuspending cells for counting and seeding into a 96-well plate.

Main Results

• Successful detachment and resuspension of cancer cells.
• Real-time imaging of T-cell interactions with tumor spheroids.
• Assessment of cytotoxicity levels over time.
• Insights into the effectiveness of CAR T-cell therapy.

Conclusions

• The method provides a reliable way to study T-cell cytotoxicity.
• Real-time imaging enhances the understanding of immune responses.
• This approach can aid in the development of more effective immunotherapies.

Frequently Asked Questions